FDA Approves Supplemental New Animal Drug Application for Florfenicol Injectable Solution

Summary

The FDA is amending its regulations to reflect the approval of a supplemental new animal drug application (NADA) for Intervet, Inc.'s florfenicol injectable solution, which is now approved to treat bovine respiratory disease pathogens including Mycoplasma bovis.